1. Allaire, J. J., Xie, Y., McPherson, J., et al. (2021). rmarkdown: Dynamic documents for R. R Package Version, 2, 10.
2. Berkel, C., & Cacan, E. (2019). Single-cell epigenomics in cancer research. Biomedical Journal of Scientific and Technical Research, 21, 15966–15973.
3. Berkel, C., & Cacan, E. (2021). GAB2 and GAB3 are expressed in a tumor stage-, grade- and histotype-dependent manner and are associated with shorter progression-free survival in ovarian cancer. Journal of Cell Communication and Signaling, 15(1), 57–70. https://doi.org/10.1007/s12079-020-00582-3
4. Berkel, C., Kucuk, B., Usta, M., et al. (2020). The effect of olaparib and bortezomib combination treatment on ovarian cancer cell lines. European Journal of Biology, 79(2), 115–123.
5. Ceccaldi, R., Liu, J. C., Amunugama, R., et al. (2015). Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair. Nature, 518(7538), 258–262. https://doi.org/10.1038/nature14184